Figure 2

Recommendation processs flowchart. ^†Antimicrobial use: used Glycopeptides or Carbapenems used 3,4-Generation Cephalosporins or Quinolones for 14 days or more ^‡Pathogenic microorganisms: Positive blood cultures, Methicillin-resistant Staphylococcus aureus Extended spectrum beta-lactamase-producing organisms, Acinetobacter baumannii Pseudomonas aeruginosa resistant to at least one among Carbapenems, Quinolones or Aminoglycosides.